Definition of Saracatinib. Meaning of Saracatinib. Synonyms of Saracatinib

Here you will find one or more explanations in English for the word Saracatinib. Also in the bottom left of the page several parts of wikipedia pages related to the word Saracatinib and, of course, Saracatinib synonyms and on the right images related to the word Saracatinib.

Definition of Saracatinib

No result for Saracatinib. Showing similar results...

Meaning of Saracatinib from wikipedia

- Saracatinib (AZD-0530) is an experimental drug being developed by AstraZeneca. It acts as a dual kinase inhibitor, with selective actions as a Src inhibitor...
- plates. Recently, as of 2021[update], a potential therapeutic candidate, saracatinib, is in phase III clinical trials as a potent heterotopic ossification...
- sapropterin dihydrochloride (USAN) sapropterin (INN) saquinavir (INN) saracatinib (USAN, INN) Sarafem sarafloxacin (INN) saralasin (INN) sarcolysin (INN)...
- developed for the treatment of chronic myelogenous leukemia by Pfizer. Saracatinib, the first Src inhibitor to show inhibition of the Src pathway in human...
- inhibitor drugs that are in clinical trials include bosutinib, bafetinib, Saracatinib(AZD-0530), XLl-999, KX01 and XL228. HSP90 inhibitor NVP-BEP800 has been...
- synaptic density imaging with 11C-UCB-J detects treatment effects of saracatinib (AZD0530) in a mouse model of Alzheimer's disease". Journal of Nuclear...
- metastasis. Inhibiting invadopodia formation by targeting Src kinase with Saracatinib in a chicken model system showed a decreased incidence of invadopodia...
- Saint-Paul L, Lucchi G, Uzan B, Ballerini P, et al. (September 2018). "Saracatinib impairs maintenance of human T-ALL by targeting the LCK tyrosine kinase...
- safety, tolerability, and central nervous system availability of AZD0530 (saracatinib) in Alzheimer's disease". Alzheimers Res Ther. 7 (1): 35. doi:10.1186/s13195-015-0119-0...
- safety, tolerability, and central nervous system availability of AZD0530 (saracatinib) in Alzheimer's disease". Alzheimer's Research & Therapy. 7 (1): 35....